Exercise Training as a Mediator for Enhancing Coronary Collateral Circulation: A Review of the Evidence.


Journal

Current cardiology reviews
ISSN: 1875-6557
Titre abrégé: Curr Cardiol Rev
Pays: United Arab Emirates
ID NLM: 101261935

Informations de publication

Date de publication:
2020
Historique:
received: 18 06 2019
revised: 29 07 2019
accepted: 05 08 2019
pubmed: 20 8 2019
medline: 2 10 2020
entrez: 20 8 2019
Statut: ppublish

Résumé

Coronary collateral vessels supply blood to areas of myocardium at risk after arterial occlusion. Flow through these channels is driven by a pressure gradient between the donor and the occluded artery. Concomitant with increased collateral flow is an increase in shear force, a potent stimulus for collateral development (arteriogenesis). Arteriogenesis is self-limiting, often ceasing prematurely when the pressure gradient is reduced by the expanding lumen of the collateral vessel. After the collateral has reached its self-limited maximal conductance, the only way to drive further increases is to re-establish the pressure gradient. During exercise, the myocardial oxygen demand is increased, subsequently increasing coronary flow. Therefore, exercise may represent a means of driving augmented arteriogenesis in patients with stable coronary artery disease. Studies investigating the ability of exercise to drive collateral development in humans are inconsistent. However, these inconsistencies may be due to the heterogeneity of assessment methods used to quantify change. This article summarises current evidence pertaining to the role of exercise in the development of coronary collaterals, highlighting areas of future research.

Identifiants

pubmed: 31424373
pii: CCR-EPUB-100317
doi: 10.2174/1573403X15666190819144336
pmc: PMC7536817
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-220

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Références

J Nucl Cardiol. 2001 Nov-Dec;8(6):687-93
pubmed: 11725265
Heart. 2014 Jan;100(2):160-6
pubmed: 24186565
Circulation. 2003 May 20;107(19):2507-11
pubmed: 12756191
Eur Heart J. 2012 Mar;33(5):614-21
pubmed: 21969521
Eur Heart J. 2010 Sep;31(17):2148-55
pubmed: 20584776
Circulation. 1988 May;77(5):1022-9
pubmed: 2834115
Curr Cardiol Rev. 2014 Feb;10(1):57-64
pubmed: 24611646
Circulation. 1951 Dec;4(6):797-815
pubmed: 14879489
Am J Physiol Heart Circ Physiol. 2018 Mar 1;314(3):H452-H463
pubmed: 29127237
Am J Hypertens. 2013 May;26(5):630-5
pubmed: 23391622
Circ Res. 1956 Mar;4(2):223-9
pubmed: 13293825
Nat Med. 2000 Apr;6(4):389-95
pubmed: 10742145
N Engl J Med. 1996 Jun 27;334(26):1703-8
pubmed: 8637515
J Rehabil Med. 2012 Jul;44(8):691-5
pubmed: 22729798
Circ Res. 2006 Sep 15;99(6):656-62
pubmed: 16931799
Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H235-42
pubmed: 15016635
Eur Heart J. 2013 Sep;34(34):2674-82
pubmed: 23739241
Angiology. 2018 Oct;69(9):803-811
pubmed: 29656656
Scott Med J. 1964 Jan;9:18-23
pubmed: 14103801
Circulation. 1979 Jul;60(1):114-21
pubmed: 445714
Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):250-7
pubmed: 17446804
Heart. 2010 Feb;96(3):202-7
pubmed: 19897461
Circulation. 1998 Feb 17;97(6):553-61
pubmed: 9494025
Kardiologiia. 2005;45(8):61-8
pubmed: 16091647
J Clin Invest. 2016 Mar 1;126(3):821-8
pubmed: 26928035
Eur Heart J. 2012 May;33(10):1223-31
pubmed: 21821843
Basic Res Cardiol. 2009 Jan;104(1):5-21
pubmed: 19101749
Circ Res. 1957 May;5(3):230-5
pubmed: 13427133
J Appl Physiol (1985). 2011 Aug;111(2):587-98
pubmed: 21565987
Circulation. 2016 Apr 12;133(15):1438-48; discussion 1448
pubmed: 26979085
Curr Cardiol Rev. 2014 Feb;10(1):65-72
pubmed: 23721076
Am J Cardiol. 1995 Oct 15;76(11):771-5
pubmed: 7572652
Eur Heart J. 2006 Oct;27(20):2406-12
pubmed: 17003048
Angiogenesis. 2001;4(4):247-57
pubmed: 12197469
Heart. 2004 Nov;90(11):1350-1
pubmed: 15486146
PLoS One. 2016 Apr 05;11(4):e0151822
pubmed: 27045935
Physiol Rev. 2008 Jul;88(3):1009-86
pubmed: 18626066
Med Sci Sports Exerc. 1999 Jan;31(1):31-7
pubmed: 9927007
Catheter Cardiovasc Interv. 2005 Jul;65(3):361-7
pubmed: 15945105
Nat Rev Cardiol. 2014 Apr;11(4):191-7
pubmed: 24395049
Circ Res. 1981 Apr;48(4):523-30
pubmed: 7460222
Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1664-8
pubmed: 15242864
J Appl Physiol (1985). 1985 Mar;58(3):785-90
pubmed: 3980383

Auteurs

Thomas Nickolay (T)

Hull York Medical School, University of Hull, Hull, HU6 7RX, United Kingdom.

Simon Nichols (S)

Centre for Sport and Exercise Science, Sheffield Hallam University, Sheffield, United Kingdom.

Lee Ingle (L)

Sports Health and Exercise Science, University of Hull, Hull, HU6 7RX, United Kingdom.

Angela Hoye (A)

Hull York Medical School, University of Hull, Hull, HU6 7RX, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH